Cancer Clinical Trial -Adagene-ADG126-P001

Cancer

Status:

Open

ClinicalTrials.gov:

NCT05405595

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Drug

ADG126

Phase

Phase I

Condition

Advanced Solid Tumors

Keywords

Anti CTLA4